DV
Therapeutic Areas
Almirall Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ebglyss (lebrikizumab) | Moderate-to-Severe Atopic Dermatitis | Approved |
| Klisyri (tirbanibulin) | Actinic Keratosis | Approved |
| IL-1RAP Inhibitor (ALM22305) | Hidradenitis Suppurativa / Inflammatory Diseases | Phase 2 |
| ALM27134 (Topical PDE4 Inhibitor) | Mild-to-Moderate Atopic Dermatitis | Phase 2 |
| ALM22307 | Prurigo Nodularis / Chronic Pruritus | Phase 1 |